Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis
New England Journal of Medicine · 28.12.2023 · 389 (26) · 2436-2445
DOI: 10.1056/nejmoa2308550 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 28.12.2023. Verfasst von Michelle N Rheault und 27 weiteren Autor:innen. Beteiligte Einrichtung: From the Division of Pediatric Nephrology, University of Minnesota Medical School, Minneapolis (M.N.R.); the Department of Laboratory Medicine and Pa…. Hauptthemen laut MEDLINE: Glomerulosclerosis, Focal Segmental, Irbesartan, Proteinuria. Die Arbeit wurde bisher 124-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: NIDDK NIH HHS, Travere Therapeutics.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Division of Pediatric Nephrology, University of Minnesota Medical School, Minneapolis (M.N.R.); the Department of Laboratory Medicine and Pathology, University of Washington, Seattle (C.E.A.); the Department of…
ORCID-Profile: Michelle N Rheault, Jonathan Barratt, Pietro Canetta
Förderung
- NIDDK NIH HHS
- Travere Therapeutics
Zitieren
APA
Rheault, M. N., Alpers, C. E., Barratt, J., Bieler, S., Canetta, P., Chae, D. W., Coppock, G., Diva, U., Gesualdo, L., Heerspink, H. J. L., Inrig, J. K., Kirsztajn, G. M., Kohan, D., Komers, R., Kooienga, L. A., Lieberman, K., Mercer, A., Noronha, I. L., Perkovic, V., …, & DUPRO Steering Committee and DUPLEX Investigators (2023). Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis. New England Journal of Medicine, 389(26), 2436-2445. https://doi.org/10.1056/nejmoa2308550
Vancouver
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, et al. Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis. New England Journal of Medicine. 2023;389(26):2436-2445. doi:10.1056/nejmoa2308550
BibTeX
@article{Rheault2023,
author = {Rheault, Michelle N and Alpers, Charles E and Barratt, Jonathan and Bieler, Stewart and Canetta, Pietro and Chae, Dong-Wan and Coppock, Gaia and Diva, Ulysses and Gesualdo, Loreto and Heerspink, Hiddo J L and Inrig, Jula K and Kirsztajn, Gianna M and Kohan, Donald and Komers, Radko and Kooienga, Laura A and Lieberman, Kenneth and Mercer, Alex and Noronha, Irene L and Perkovic, Vlado and Radhakrishnan, Jai and Rote, William and Rovin, Brad and Tesar, Vladimir and Trimarchi, Hernán and Tumlin, James and Wong, Muh Geot and Trachtman, Howard and DUPRO Steering Committee and DUPLEX Investigators, DUPRO Steering Committee and DUPLEX Investigators},
title = {Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis},
journal = {New England Journal of Medicine},
year = {2023},
volume = {389},
number = {26},
pages = {2436--2445},
doi = {10.1056/nejmoa2308550}
}
EUVIMED